Publications by authors named "John Shively"

Claim this Profile
C
Combination Image-Guided and Antibody-Targeted α-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors.
Maciej Kujawski, Eric Aniogo, Patty Wong, Susanta Hui, Hemendra Ghimire, John E Shively

J Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal epithelial Ceacam1 deficiency prevents steroid-refractory acute gut graft-versus-host disease.
Qingxiao Song, Moqian Zheng, Qinjian Li, Xiwei Wu, Boxi Lin, John Shively

JCI Insight· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of healing critical-sized calvarial defects by LL-37-generated monoosteophils.
Keith Le, Huinan Liu, Chaoxing Zhang, Zhuo Li, Tove Olafsen, John E Shively

Front Bioeng Biotechnol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Anti-CEA C2 Domain-Deleted Antibody (M5A∆C2) for the PET Imaging of Colorectal Cancer.
Jitender Jitender, Teresa Hong, Anakim Sherman, Patty Wong, Eric Aniogo, John E Shively

Mol Imaging Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors.
Eric Aniogo, Lindsay Williams, Teresa Hong, Patty Wong, Susanta K Hui, John E Shively

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy.
Eric Aniogo, Maciej Kujawski, Dennis Awuah, Seung E Cha, Ruby Espinosa, John E Shively

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current investigation of carcinoembryonic antigen cell adhesion molecule (CEACAM) biology summary of the 32nd CEA symposium: 20-23 September 2024. Würzburg, Germany.
James M Fleckenstein, Sonia M Najjar, Wolfgang Zimmermann, Christof R Hauck, Quynh Nguyen, John E Shively

Eur J Clin Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism and function of CEACAM1 splice isoforms.
Kenneth J Dery, Sonia M Najjar, Nicole Beauchemin, John E Shively, Jerzy W Kupiec-Weglinski

Eur J Clin Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of lipid storage and inflammation in the liver by CEACAM1.
Sonia M Najjar, John E Shively

Eur J Clin Invest· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers.
Maxim Kuznetsov, Vikram Adhikarla, Enrico Caserta, Xiuli Wang, John E Shively

Cancer Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.
Jasmine Zain, Ni-Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla, John E Shively

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy.
Vikram Adhikarla, Dennis Awuah, Enrico Caserta, Megan Minnix, Maxim Kuznetsov, John E Shively

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers.
Maxim Kuznetsov, Vikram Adhikarla, Enrico Caserta, Xiuli Wang, John E Shively

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens.
Nicole M Mattson, Anthony K N Chan, Kazuya Miyashita, Elizaveta Mukhaleva, Wen-Han Chang, John E Shively

Nat Struct Mol Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of IL-2-antibody to IL-2-Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumors.
Lindsay Williams, Lin Li, Paul J Yazaki, Patty Wong, Teresa Hong, John E Shively

Cancer Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody.
Michela Centonze, Valentina Fiori, Maciej Kujawski, Lin Li, Patty Wong, John E Shively

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Matthew C Hernandez, Paul Yazaki, Joanne E Mortimer, Dave Yamauchi, Erasmus Poku, John Shively

Nucl Med Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
Michael A Turner, Siamak Amirfakhri, Hiroto Nishino, Nicholas C Neel, Mojgan Hosseini, John E Shively

J Surg Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma.
Dennis Awuah, Lin Li, Lindsay Williams, Ryan Urak, Maciej Kujawski, John E Shively

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Step Automatic Radiosynthesis and Evaluation of [F]TM-30089 as GPR44 Radiotracer.
Jiangling Peng, Wei Tang, Jeffrey Rawson, Lynn Miao, Nelson Gonzalez, John E Shively

Pharmaceuticals (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of IL-2-Fc-antibody conjugates by click chemistry.
Lindsay Williams, Lin Li, Paul J Yazaki, Patty Wong, Aaron Miller, John E Shively

Biotechnol J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma.
Dennis Awuah, Megan Minnix, Enrico Caserta, Theophilus Tandoh, Vikram Adhikarla, John E Shively

Cancer Immunol Immunother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
Thinzar M Lwin, Megan Minnix, Lin Li, Anakim Sherman, Teresa Hong, John E Shively

Mol Imaging Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers.
Runkai Yin, Kelly X Huang, Lina A Huang, Melinda Ji, Hanyi Zhao, John E Shively

Pharmaceuticals (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Uptake of [F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model.
Junfeng Li, Weidong Hu, Jiangling Peng, Patty Wong, Fouad Kandeel, John E Shively

Pharmaceuticals (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis